Q4 2018 EPS Estimates for Intuitive Surgical, Inc. (ISRG) Raised by Analyst

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Research analysts at Piper Jaffray Companies upped their Q4 2018 earnings per share (EPS) estimates for shares of Intuitive Surgical in a note issued to investors on Wednesday, January 9th. Piper Jaffray Companies analyst J. Mckim now forecasts that the medical equipment provider will post earnings per share of $2.53 for the quarter, up from their prior forecast of $2.47. Piper Jaffray Companies has a “Overweight” rating and a $625.00 price objective on the stock. Piper Jaffray Companies also issued estimates for Intuitive Surgical’s Q2 2019 earnings at $2.69 EPS and Q3 2019 earnings at $2.58 EPS.

Several other equities analysts have also weighed in on the stock. Northland Securities restated a “sell” rating and set a $375.00 price objective on shares of Intuitive Surgical in a research report on Thursday. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $541.00 price objective for the company in a research report on Thursday. ValuEngine upgraded shares of Intuitive Surgical from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. Finally, Citigroup reduced their price objective on shares of Intuitive Surgical from $601.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, January 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $563.17.

NASDAQ:ISRG opened at $505.32 on Friday. Intuitive Surgical has a twelve month low of $380.00 and a twelve month high of $581.12. The stock has a market cap of $59.05 billion, a PE ratio of 70.28, a price-to-earnings-growth ratio of 3.44 and a beta of 1.07.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The firm had revenue of $920.90 million for the quarter, compared to analysts’ expectations of $916.22 million. During the same quarter last year, the company earned $2.77 EPS. Intuitive Surgical’s quarterly revenue was up 14.0% on a year-over-year basis.

In related news, EVP David J. Rosa sold 32,500 shares of the firm’s stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $500.86, for a total transaction of $16,277,950.00. Following the completion of the sale, the executive vice president now directly owns 44,208 shares in the company, valued at $22,142,018.88. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Jamie Samath sold 864 shares of the firm’s stock in a transaction that occurred on Tuesday, October 23rd. The stock was sold at an average price of $499.21, for a total transaction of $431,317.44. Following the sale, the vice president now owns 257 shares of the company’s stock, valued at $128,296.97. The disclosure for this sale can be found here. Over the last quarter, insiders sold 72,491 shares of company stock valued at $37,767,784. Corporate insiders own 2.20% of the company’s stock.

Several hedge funds have recently bought and sold shares of the stock. FMR LLC increased its position in shares of Intuitive Surgical by 19.2% in the 2nd quarter. FMR LLC now owns 6,629,648 shares of the medical equipment provider’s stock valued at $3,172,155,000 after acquiring an additional 1,068,107 shares during the period. Envestnet Asset Management Inc. increased its position in shares of Intuitive Surgical by 2.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 4,229 shares of the medical equipment provider’s stock valued at $2,022,000 after acquiring an additional 117 shares during the period. Raymond James & Associates increased its position in shares of Intuitive Surgical by 23.8% in the 2nd quarter. Raymond James & Associates now owns 31,778 shares of the medical equipment provider’s stock valued at $15,205,000 after acquiring an additional 6,111 shares during the period. Voya Investment Management LLC increased its position in shares of Intuitive Surgical by 3.6% in the 2nd quarter. Voya Investment Management LLC now owns 42,362 shares of the medical equipment provider’s stock valued at $20,269,000 after acquiring an additional 1,491 shares during the period. Finally, Flagship Harbor Advisors LLC increased its position in shares of Intuitive Surgical by 23.7% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 985 shares of the medical equipment provider’s stock valued at $471,000 after acquiring an additional 189 shares during the period. Institutional investors and hedge funds own 84.14% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Further Reading: What type of investment options does a Roth IRA provide?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply